An open-label, one-sequence cross-over study to investigate the effect of deferasirox on the pharmacokinetics of midazolam in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 29 Sep 2009
At a glance
- Drugs Deferasirox; Midazolam
- Indications Anxiety disorders; Seizures
- Focus Pharmacokinetics
- Sponsors Novartis
- 29 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Feb 2007 New trial record.